210 related articles for article (PubMed ID: 27362910)
1. Cell-free DNA testing of an extended range of chromosomal anomalies: clinical experience with 6,388 consecutive cases.
Pescia G; Guex N; Iseli C; Brennan L; Osteras M; Xenarios I; Farinelli L; Conrad B
Genet Med; 2017 Feb; 19(2):169-175. PubMed ID: 27362910
[TBL] [Abstract][Full Text] [Related]
2. Prenatal Genome-Wide Cell-Free DNA Screening: Three Years of Clinical Experience in a Hospital Prenatal Diagnostic Unit in Spain.
Pedrola Vidal L; Roselló Piera M; Martín-Grau C; Rubio Moll JS; Gómez Portero R; Marcos Puig B; Cervera Zamora JV; Quiroga R; Orellana Alonso C
Genes (Basel); 2024 Apr; 15(5):. PubMed ID: 38790198
[TBL] [Abstract][Full Text] [Related]
3. Clinical utility of noninvasive prenatal screening for expanded chromosome disease syndromes.
Liang D; Cram DS; Tan H; Linpeng S; Liu Y; Sun H; Zhang Y; Tian F; Zhu H; Xu M; Wang H; Yu F; Wu L
Genet Med; 2019 Sep; 21(9):1998-2006. PubMed ID: 30828085
[TBL] [Abstract][Full Text] [Related]
4. Detection of fetal subchromosomal aberration with cell-free DNA screening led to diagnosis of parental translocation: Review of 11344 consecutive cases in a university hospital.
Qian YQ; Wang XQ; Chen M; Luo YQ; Yan K; Yang YM; Liu B; Wang LY; Huang YZ; Li HG; Pan HY; Jin F; Dong MY
Eur J Med Genet; 2019 Feb; 62(2):115-123. PubMed ID: 29929010
[TBL] [Abstract][Full Text] [Related]
5. Positive predictive value estimates for cell-free noninvasive prenatal screening from data of a large referral genetic diagnostic laboratory.
Petersen AK; Cheung SW; Smith JL; Bi W; Ward PA; Peacock S; Braxton A; Van Den Veyver IB; Breman AM
Am J Obstet Gynecol; 2017 Dec; 217(6):691.e1-691.e6. PubMed ID: 29032050
[TBL] [Abstract][Full Text] [Related]
6. Prospective chromosome analysis of 3429 amniocentesis samples in China using copy number variation sequencing.
Wang J; Chen L; Zhou C; Wang L; Xie H; Xiao Y; Zhu H; Hu T; Zhang Z; Zhu Q; Liu Z; Liu S; Wang H; Xu M; Ren Z; Yu F; Cram DS; Liu H
Am J Obstet Gynecol; 2018 Sep; 219(3):287.e1-287.e18. PubMed ID: 29852155
[TBL] [Abstract][Full Text] [Related]
7. Performance of prenatal cfDNA screening for sex chromosomes.
Martin K; Dar P; MacPherson C; Egbert M; Demko Z; Parmar S; Hashimoto K; Haeri S; Malone F; Wapner RJ; Roman AS; Khalil A; Faro R; Madankumar R; Strong N; Silver RM; Vohra N; Hyett J; Rabinowitz M; Kao C; Hakonarson H; Jacobsson B; Norton ME
Genet Med; 2023 Aug; 25(8):100879. PubMed ID: 37154148
[TBL] [Abstract][Full Text] [Related]
8. Clinical, Cytogenetic and Molecular Cytogenetic Outcomes of Cell-Free DNA Testing for Rare Chromosomal Anomalies.
Basaran S; Has R; Kalelioglu IH; Sarac Sivrikoz T; Karaman B; Kirgiz M; Dehgan T; Kalayci T; Ozsait Selcuk B; Miny P; Yuksel A
Genes (Basel); 2022 Dec; 13(12):. PubMed ID: 36553656
[TBL] [Abstract][Full Text] [Related]
9. Accuracy and clinical value of maternal incidental findings during noninvasive prenatal testing for fetal aneuploidies.
Brison N; Van Den Bogaert K; Dehaspe L; van den Oever JM; Janssens K; Blaumeiser B; Peeters H; Van Esch H; Van Buggenhout G; Vogels A; de Ravel T; Legius E; Devriendt K; Vermeesch JR
Genet Med; 2017 Mar; 19(3):306-313. PubMed ID: 27584908
[TBL] [Abstract][Full Text] [Related]
10. Analysis of cell-free DNA in maternal blood in screening for fetal aneuploidies: updated meta-analysis.
Gil MM; Quezada MS; Revello R; Akolekar R; Nicolaides KH
Ultrasound Obstet Gynecol; 2015 Mar; 45(3):249-66. PubMed ID: 25639627
[TBL] [Abstract][Full Text] [Related]
11. Performance of a cell-free DNA prenatal screening test, choice of prenatal procedure, and chromosome conditions identified during pregnancy after low-risk cell-free DNA screening.
Scarff KL; Flowers N; Love CJ; Archibald AD; Hunt CE; Giouzeppos O; Elliott J; Delatycki MB; Pertile MD
Prenat Diagn; 2023 Feb; 43(2):213-225. PubMed ID: 36617980
[TBL] [Abstract][Full Text] [Related]
12. Detection of fetal copy number variants by non-invasive prenatal testing for common aneuploidies.
Li R; Wan J; Zhang Y; Fu F; Ou Y; Jing X; Li J; Li D; Liao C
Ultrasound Obstet Gynecol; 2016 Jan; 47(1):53-7. PubMed ID: 26033469
[TBL] [Abstract][Full Text] [Related]
13. Rare autosomal trisomies: comparison of detection through cell-free DNA analysis and direct chromosome preparation of chorionic villus samples.
Benn P; Malvestiti F; Grimi B; Maggi F; Simoni G; Grati FR
Ultrasound Obstet Gynecol; 2019 Oct; 54(4):458-467. PubMed ID: 31237735
[TBL] [Abstract][Full Text] [Related]
14. Inherited unbalanced reciprocal translocation with 3q duplication and 5p deletion in a foetus revealed by cell-free foetal DNA (cffDNA) testing: a case report.
Ali TM; Mateu-Brull E; Balaguer N; Dantas C; Borges HR; de Oliveira MQG; Rodrigo L; Campos-Galindo I; Navarro R; Milán M
Eur J Med Res; 2021 Jun; 26(1):64. PubMed ID: 34187576
[TBL] [Abstract][Full Text] [Related]
15. Non-invasive prenatal testing for fetal chromosomal abnormalities by low-coverage whole-genome sequencing of maternal plasma DNA: review of 1982 consecutive cases in a single center.
Lau TK; Cheung SW; Lo PS; Pursley AN; Chan MK; Jiang F; Zhang H; Wang W; Jong LF; Yuen OK; Chan HY; Chan WS; Choy KW
Ultrasound Obstet Gynecol; 2014 Mar; 43(3):254-64. PubMed ID: 24339153
[TBL] [Abstract][Full Text] [Related]
16. Contribution of maternal copy number variations to false-positive fetal trisomies detected by noninvasive prenatal testing.
Zhou X; Sui L; Xu Y; Song Y; Qi Q; Zhang J; Zhu H; Sun H; Tian F; Xu M; Cram DS; Liu J
Prenat Diagn; 2017 Apr; 37(4):318-322. PubMed ID: 28152582
[TBL] [Abstract][Full Text] [Related]
17. Three years of clinical experience with a genome-wide cfDNA screening test for aneuploidies and copy-number variants.
Soster E; Boomer T; Hicks S; Caldwell S; Dyr B; Chibuk J; Almasri E
Genet Med; 2021 Jul; 23(7):1349-1355. PubMed ID: 33731879
[TBL] [Abstract][Full Text] [Related]
18. Copy number variation sequencing-based prenatal diagnosis using cell-free fetal DNA in amniotic fluid.
Qi Q; Lu S; Zhou X; Yao F; Hao N; Yin G; Li W; Bai J; Li N; Cram DS
Prenat Diagn; 2016 Jun; 36(6):576-83. PubMed ID: 27084671
[TBL] [Abstract][Full Text] [Related]
19. [Clinical value of routine non-invasive prenatal testing for the screening of non-target chromosomal abnormalities].
Zhang Y; Yan L; Liu Y; Li H
Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2020 Jun; 37(6):621-626. PubMed ID: 32472537
[TBL] [Abstract][Full Text] [Related]
20. Noninvasive prenatal screening for fetal trisomies 21, 18, 13 and the common sex chromosome aneuploidies from maternal blood using massively parallel genomic sequencing of DNA.
Porreco RP; Garite TJ; Maurel K; Marusiak B; ; Ehrich M; van den Boom D; Deciu C; Bombard A
Am J Obstet Gynecol; 2014 Oct; 211(4):365.e1-12. PubMed ID: 24657131
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
